Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...

Bhubaneswar: In a major move aimed at strengthening the healthcare infrastructure in Odisha, the state government has ...

Life can feel like a juggling act, can’t it? Between work deadlines, family responsibilities, and the endless stream of ...

Marquee owns and manages a portfolio of established global brands across consumer products and channels from luxury goods to ...

No-code platforms can offer the ability to surface business insights, but their true value lies in enabling action.

One often overlooked but critical component of cybersecurity is software asset management (SAM). By managing, monitoring and ...

On February 12, 2025, the U.S. Army achieved a significant milestone in its Precision Strike Missile (PrSM) program by ...

Lesley’s takes are hot but also realistic and attainable. For example, if we can come together to bridge the critical ...

Welcome to the Gogoro Inc 2024 fourth quarter and full year earnings call. This conference call is now being recorded and broadcasted live over the internet. Webcast replay will be available within an ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...